Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib*, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine* and Jean Sibilia

Arthritis Research & Therapy 2009, 11:R95 doi:10.1186/ar2740

Accesses  

  • Last 30 days: 214 accesses
  • Last year: 2088 accesses
  • All time: 10494 accesses

Cited by

BioMed Central: 1 citation

Editorial   Free

More about masitinib

Ulrich A Walker Arthritis Research & Therapy 2009, 11:120 (13 July 2009)